Tacrolimus Market Share, Demand Analysis, Growth, Trends and Forecast - 2028The global tacrolimus market is anticipated to grow at a CAGR of 4.5% during the forecast period (2022-2028).
Tacrolimus inhibits the initiation of serine-threonine phosphatase, calcineurin, in T lymphocytes. This suppresses T lymphocyte activation and the consequent generation of cytotoxic lymphocytes, thereby controlling the process that leads to organ rejection. Available in various dosage forms such as tablets, injections, and capsules, it is one of the most sold immunosuppressant drugs in the market. This medication works by supporting the body to accept the new organ and lower the risk of organ rejection to prevent the body from attacking and rejecting the transplanted organ which could be liver, kidney, or even heart. The growth of the market is attributed to the rising number of organ transplant among adult and pediatric patients globally.
(Get 15% Discount on Buying this Report)
A full report of Global Tacrolimus Market is available at: https://orionmarketreports.com/tacrolimus-market/97696/
For instance, as per the Organ Procurement and Transplantation Network (OPTN) 117,000+ number of men, women, and children were on the national transplant waiting list as of July 2017 in the US and 17,155 organ transplants were done so far in 2017. Further, tacrolimus is also used in treating certain dermatological conditions such as atopic dermatitis and psoriasis. Another key trend observed in the market is that people have become more conscious about dermatological issues. Thus, atopic dermatitis being a prevalent dermatological issue that requires substantial medical solution such as tacrolimus. Some forms of tacrolimus are available in generic form and are given orally or by injection. It contains calcineurin inhibitors that can stop the immune system from producing substances that may cause eczema.
Some key players operating in the market include GlaxoSmithKline plc, Astellas Pharma Inc., and Mylan NV, among others. The market players are focusing on several strategies, such as mergers and acquisitions, partnerships, product launches, and collaborations. For instance, in December 2020, Biocon Ltd. announced the launch of Tacrolimus capsules in the US. In November 2020, Lupin Ltd. announced the launch of Tacrolimus Capsules USP, 0.5 mg, 1 mg, and 5 mg, after Lupin's alliance partner Concord Biotech Ltd. (Concord) received an approval for its ANDA from the US Food and Drug Administration (US FDA). Tacrolimus Capsules USP, 0.5 mg, 1 mg, and 5 mg, are the generic equivalent of Prograf Capsules, 0.5 mg, 1 mg, and 5 mg, of Astellas Pharma US, Inc., and are indicated for the prophylaxis of organ rejection, in adult patients receiving allogeneic kidney transplant, liver transplant, and heart transplant, and in pediatric patients receiving allogeneic liver transplants, in combination with other immunosuppressants.
• The market number available for - 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By Type
o By Application
• Regions covered-
o North America
o Rest of the World
• Competitive Landscape: GlaxoSmithKline plc, Astellas Pharma Inc., and Mylan NV, among others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Tacrolimus Market Report by Segment
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Contact no: +91 780-304-0404
Orion Market Reports (OMR) endeavors to provide an exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and the most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Tacrolimus Market Share, Demand Analysis, Growth, Trends and Forecast - 2028 here
News-ID: 2600661 • Views: 449
More Releases from Orion Market Reports
Fishing Hooks Market Growth Drivers, Developments, Technology And Future Trends …
Fishing hooks market is projected to grow at a CAGR of 5.5% from 2023 to 2029. The growth in the market can be attributed to the increasing demand for fishing hooks from specialty and sports shops, department and discount stores, and online retail channels. Future market target goals, target customers' demands and business expansion ideas are all covered in this Fishing Hooks Market research report. Facility expansions, workforce development, major
CA 125 Test Market 2023 Trends with Analysis on Key Players
CA 125 Test market is projected to grow at a CAGR of 6.5% during the forecast period from 2023 to 2029. The growth in this market can be attributed to the increasing incidence of ovarian cancer, rising awareness about early detection and diagnosis of ovarian cancer, and technological advancements in CA 125 Test products. Future market target goals, target customers' demands and business expansion ideas are all covered in this
Ad Blue Market Value Projected to Expand by 2029
Ad Blue Market is estimated to grow from USD 1.2 Billion in 2021, at a CAGR of 7.1% between 2023 and 2029, with the revenue expected to reach by the end-2029. Future market target goals, target customers' demands and business expansion ideas are all covered in this Ad Blue Market research report. Facility expansions, workforce development, major developments, market share and customers' purchasing nature are also emphasized in this global
Cholesterl Market Sluggish Growth Rate Foreseen by 2023-2029
Cholesterol market will grow at a CAGR of 5.2% during 2023-2029. There is an increasing demand for cholesterol in the pharmaceutical industry, which is likely to drive the growth of this market. Future market target goals, target customers' demands and business expansion ideas are all covered in this Cholesterl Market research report. Facility expansions, workforce development, major developments, market share and customers' purchasing nature are also emphasized in this global
More Releases for Tacrolimus
Tacrolimus Ointment Market Size & Growth Analysis Report, 2022-2028
The global tacrolimus ointment market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Tacrolimus ointment suppresses the immune system and the inflammation by inhibiting an enzyme (calcineurin) crucial for the multiplication of T-cells, cells that are required for activation of the immune system. Tacrolimus ointment is a drug that is applied to the skin for the treatment of atopic dermatitis (eczema). Further, atopic dermatitis is
2022 Tacrolimus Market Report- Size, Outlook, Share & Forecast To 2025 | Huapont …
Tacrolimus Market report also focuses on comprehensive market revenue streams along with growth patterns, Local reforms, COVID Impact analysis with a focused approach on market trends, and the overall growth of the Tacrolimus Market. Moreover, Tacrolimus Market report describes the market division based on various parameters and attributes that are based on geographical distribution, product types, applications, etc. Download FREE PDF of the Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5449468 Tacrolimus market is segmented by Type
Tacrolimus Injection Market 2019 | Analyzing The Impact Followed By Restraints, …
" DataIntelo offers a detailed report on Global Tacrolimus Injection Market. The report is a comprehensive research study that provides the scope of Tacrolimus Injection market size, industry growth opportunities and challenges, current market trends, potential players, and expected performance of the market in regions for the forecast period from 2020 to 2027. This report highlights key insights on the market focusing on the possible requirements of the clients and assisting
Global Tacrolimus Market Overview by Business Manufactures with Forecast Analysi …
In this report, the global Tacrolimus market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Tacrolimus for these regions, from 2013 to 2025 (forecast), covering
Excellent Growth of Tacrolimus Market | Global Forecasts 2018 - 2025
This report studies the global Tacrolimus market status and forecast, categorizes the global Tacrolimus market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa). The global Tacrolimus market is valued at million US$ in 2017 and will reach million US$ by
Tacrolimus Market 2018 Global Trends, market Share, Growth, Analysis, Opportunit …
This market research report on the Tacrolimus Market is an all-inclusive study of the business sectors up-to-date outlines, industry enhancement drivers, and manacles. It provides market projections for the coming years. It contains an analysis of late augmentations in innovation, Porter's five force model analysis and progressive profiles of hand-picked industry competitors. The report additionally formulates a survey of minor and full-scale factors charging for the new applicants in the